ID   FH44
AC   CVCL_E629
SY   KE; TER334; TER-334; Ter 334; TER384; TER-384; Ter 384; TER467; TER-467; Ter 467; TER522; TER-522; Ter-522; Ter 522
DR   dbMHC; 48819
DR   IHW; IHW09432
DR   IPD-IMGT/HLA; 10908
DR   Wikidata; Q54834832
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/364cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/CX390reportFinal.pdf
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*02:03:01,11:01:01:01; B*15:02:01:01,38:02:01; C*07:02:01:01,08:147; DPA1*02:02:02:01; DPB1*02:02,05:01:01; DQA1*01:03:01:05,03:03:01:03; DQB1*04:01:01:01; DRB1*04:05:01:01;08:14:01; DRB4*01:03:01:01 (IPD-IMGT/HLA=10908).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//